期刊文献+

肝切除术加区域性淋巴结清扫治疗肝门部胆管癌 被引量:2

Hepatectomy with Regional Lymphadenectomy for Hilar Cholangiocarcinoma
下载PDF
导出
摘要 目的探讨肝切除术加区域性淋巴结清扫治疗肝门部胆管癌的疗效。方法回顾性分析1990年1月~2004年12月收治的60例肝门部胆管癌的根治性治疗资料。所有病人均给予肝外胆管切除及区域淋巴清扫。根据肝切除情况分为2组:肝切除组38例,未切肝组22例。结果肝切除组和未切肝组术后并发症发生率分别为31.58%、9.09%,两者有统计学差异(P<0.05),两组病死率分别为5.26%、4.55%,无统计学差异(P>0.05)。肝切除组1、2、3年累积生存率分别为84.21%、60.53%、39.47%,未切肝组分别为72.73%、31.82%、13.64%,两组比较,第1年无差别(P>0.05),第2、3年有统计学差异(P<0.05)。结论肝切除术加区域性淋巴结清扫是提高肝门部胆管癌根治性切除率、生存率和改善生活质量的重要手段,骨骼化淋巴清扫应成为操作规范。 Objective To assess the outcome of hepatectomy with regional lymphadenectomy for hilar cholangiocarcinoma. Methods The clinical data of 60 patients who underwent radical resection for hilar cholangiocarcinoma from January 1990 to December 2004 were analyzed retrospectively. All patients were divided into two groups : group A underwent hepatectomy ( n = 38 ) and group B did not receive hepatectomy ( n = 22). All patients underwent extrahepatic bile duct resection and regional lymphadenectomy. Results The postoperative morbidity and mortality in group A and B were 31.58% , 5.26% and 9.09%, 4.55% respectively. There was significant difference in terms of postoperative morbidity between two groups (P 〈 0.05 ), but not in terms of mortality(P 〉0.05). The 1-,2- and 3-year overall survival rates in group A and group B were 84.21% ,60.53%, 39.47% and 72.73%, 31.82%, 13.64% respectively. There were significant difference in survival rates between two groups of the 2- and 3-year survival ( P 〈 0.05 ). Conclusions Hepatectomy with regional lymphadenectomy for hilar cholangiocarcinoma are critical to improve the survival. Skeletonization of the hepatoduodenal ligament should be comprised by any means in the procedure.
出处 《中国现代手术学杂志》 2005年第6期415-418,共4页 Chinese Journal of Modern Operative Surgery
关键词 胆管肿瘤 肝切除术 淋巴结切除术 bile duct neoplasms hepatectomy lymph node excision
  • 相关文献

参考文献10

  • 1Tsao JI,Nimura Y,Kamiya J,et al.Management of hilar cholangiocarcinoma:comparison of an American and Japanese experience[J].Ann Surg,2000,232(2):166-174. 被引量:1
  • 2黄志强.肝门部胆管癌外科治疗——我们要走向何方?[J].肝胆外科杂志,2003,11(5):321-322. 被引量:32
  • 3Rea DJ,Munoz-Juarez M,Farnell MB,et al.Major hepatic resection for hilar cholangiocarcinoma:analysis of 46 patients [J].Arch Surg,2004,139(5):514-523. 被引量:1
  • 4Nimura Y,Kamiya J,Kondo S,et al.Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma:Nagoya experience[J].J Hepatobiliary Pancreat Surg,2000(3):155-162. 被引量:1
  • 5Kitagawa Y,Nagino M,Kamiya J,et al.Lymph node metastasis from hilar cholangiocarcinoma:audit of 110 patients who underwent regional and paraaortic node dissection [J].Ann Surg,2001,233(3):385-392. 被引量:1
  • 6黄志强.肝门部胆管癌外科治疗——现状与思考[J].消化外科,2005,4(5):305-306. 被引量:22
  • 7Akatsu T,Shimazu M,Kawachi S,et al.Long-term survival of intrahepatic cholangiocarcinoma with hilar lymph node metastasis and portal vein involvement [J].Hepatogastroenterology,2005,52(62):603-605. 被引量:1
  • 8Zervos EE,Pearson H,Durkin AJ,et al.In-continuity hepatic resection for advanced hilar cholangiocarcinoma[J].Am J Surg,2004,188(5):584-588. 被引量:1
  • 9王建立,李森,冯立民,徐克森,董典宁,宋钦华,寿楠海.联合门静脉切除的肝门部胆管癌根治切除术[J].中华肝胆外科杂志,2005,11(3):167-168. 被引量:8
  • 10Lillemoe KD,Cameron JL.Surgery for hilar cholangiocarcinoma:the Johns Hopkins approach[J].J Hepatobiliary Pancreat Surg,2000,7(2):115-121. 被引量:1

二级参考文献20

  • 1李森.肠系膜上静脉“胰后干”和门静脉干测量及临床意义[J].肝胆胰脾外科杂志,1995,1(4):240-241. 被引量:4
  • 2孙占祺.肝门胆管癌的诊断和治疗[J]..第九届全国普通外科学术会议资料汇编[C].无锡,2002.143. 被引量:2
  • 3杨德同 周家华.江苏省90年代胆管癌流行病学调查分析[J]..中华外科学会''99北京外科周学术会议资料汇编[C].,1999.246-247. 被引量:1
  • 4梁力建.肝门部胆管癌外科治疗[J]..中华外科学会''99北京外科周学术会议资料汇编[C].,1999.217. 被引量:1
  • 5Kurosaki I,Tsukada K,Hatadeyama K,et al. The mode of lymphatic spread in carcinoma of the bile duct[J]. Am J Surg, 1996,172:239-243. 被引量:1
  • 6Burke EC,Jamagin WR,Hochwald SN,et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation,and a presurgical clinical staging system[J]. Ann Surg, 1998,228:385-394. 被引量:1
  • 7Makuuchi M, Yamasaki S, Hasegawa H,et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma : a preliminary report[J]. Surgery, 1990,107 :521-527. 被引量:1
  • 8Nakeeb A, Pitt HA, Sohn TA,et al. Cholangiocarcinoma :a spectrum of intrahepatic, perihilar, and distal tumors[J]. Ann Surg,1996,224:463-475. 被引量:1
  • 9Nimura Y,Hayakawa N,Kamiya J,et al. Hepatectomy for hilar bile duct cancer[J]. Asian J Surg, 1996,19 : 94. 被引量:1
  • 10Kawasaki S,Imamura H,Kobayashi A,et al. Results of surgical resection for patients with hilar bile duet cancer:Application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization[J]. Ann Surg,2003,238(1):84-92. 被引量:1

共引文献56

同被引文献8

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部